Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to identify abnormalities in circadian-ordered gene expression to improve our understanding of disease phenotypes, etiology, risk stratification, resilience, and therapeutic management in diseases.

Deadlines:

  • Letter of Intent Due Date(s): September 7, 2019
  • Application Due Date(s): October 7, 2019
  • AIDS Application Due Date(s): November 7, 2019
     

RFA-HL-20-016 Expiration Date November 08, 2019

Agency Website

Amount

$1,600,000

Amount Description

Application budgets may not exceed direct costs of $400,000 per year.

The maximum project period is four years. The scope of the proposed project should determine the project period.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Basic Science

External Deadline

October 7, 2019